Where GeneDx Hldgs Stands With Analysts
Portfolio Pulse from Benzinga Insights
GeneDx Hldgs (NASDAQ:WGS) has received indifferent ratings from four analysts in the last quarter, with an average price target of $8.0, implying an upside from the current price of $5.94. This average has decreased by 45.76% from the previous average price target of $14.75.
August 09, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GeneDx Hldgs has received indifferent ratings from analysts, with a lower price target than previously.
The indifferent ratings from analysts and the decrease in the average price target could potentially impact the stock price of GeneDx Hldgs. However, as the ratings are indifferent, the impact may not be significant.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100